Clovis Oncology, Inc. Deferred Revenue
Clovis Oncology, Inc. had Deferred Revenue of $2.75 million as of 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2017-11-02
- 2017-09-30: Deferred Revenue $2.75M.
| Period end | Deferred Revenue |
|---|---|
| 2017-09-30 | $2.75M 10-Q · filed 2017-11-02 |